| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phospholipase binding | 5.13e-04 | 32 | 21 | 2 | GO:0043274 | |
| GeneOntologyMolecularFunction | actinin binding | 9.27e-04 | 43 | 21 | 2 | GO:0042805 | |
| MousePheno | chromosomal instability | 1.96e-04 | 109 | 15 | 3 | MP:0008866 | |
| MousePheno | decreased tumor-free survival time | 2.23e-04 | 21 | 15 | 2 | MP:0014237 | |
| MousePheno | abnormal tumor-free survival time | 2.23e-04 | 21 | 15 | 2 | MP:0014235 | |
| MousePheno | abnormal chromosome stability | 2.30e-04 | 115 | 15 | 3 | MP:0010094 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 9.55e-05 | 15 | 14 | 2 | MM1439 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.09e-04 | 16 | 14 | 2 | M8516 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 4.59e-04 | 158 | 14 | 3 | MM14791 | |
| Pathway | PID_ATM_PATHWAY | 5.05e-04 | 34 | 14 | 2 | M84 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21404461 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 26446986 | ||
| Pubmed | 1.56e-05 | 10 | 21 | 2 | 23001180 | ||
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 3.13e-05 | 102 | 21 | 3 | 15778465 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 5.94e-05 | 361 | 21 | 4 | 30344098 | |
| Pubmed | 6.55e-05 | 20 | 21 | 2 | 21689717 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.99e-04 | 190 | 21 | 3 | 15161933 | |
| Pubmed | 2.85e-04 | 215 | 21 | 3 | 35973513 | ||
| Pubmed | 3.26e-04 | 225 | 21 | 3 | 12168954 | ||
| GeneFamily | LIM domain containing | 9.29e-04 | 59 | 14 | 2 | 1218 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.60e-06 | 186 | 21 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.18e-04 | 49 | 9 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_37_HEMATO_RELATED_2 | |
| Computational | Genes in the cancer module 331. | 1.68e-03 | 75 | 9 | 2 | MODULE_331 | |
| Disease | serum albumin measurement | 4.89e-04 | 592 | 19 | 4 | EFO_0004535 | |
| Disease | Adenocarcinoma of large intestine | 1.73e-03 | 96 | 19 | 2 | C1319315 | |
| Disease | spine bone mineral density | 2.64e-03 | 119 | 19 | 2 | EFO_0007701 | |
| Disease | Colonic Neoplasms | 4.26e-03 | 152 | 19 | 2 | C0009375 | |
| Disease | Malignant tumor of colon | 4.65e-03 | 159 | 19 | 2 | C0007102 | |
| Disease | non-alcoholic fatty liver disease | 6.04e-03 | 182 | 19 | 2 | EFO_0003095 | |
| Disease | atopic asthma | 7.18e-03 | 199 | 19 | 2 | EFO_0010638 | |
| Disease | Colorectal Carcinoma | 9.78e-03 | 702 | 19 | 3 | C0009402 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.02e-02 | 239 | 19 | 2 | EFO_0010934 | |
| Disease | physical activity measurement | 1.07e-02 | 245 | 19 | 2 | EFO_0008002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PKEWHKASARARSKT | 116 | Q86W67 | |
| RSPHRKWSDSSKQDD | 221 | Q9NYV4 | |
| TSEKFSWPAKERSRK | 346 | Q9BXX2 | |
| KRSASWGSTDHRKEI | 141 | Q9C073 | |
| RHSALWEKPSTEKET | 876 | Q8WWL7 | |
| RRASHGSEKKSAWRK | 126 | Q8IW93 | |
| DSKCLHFTPKDWSKR | 496 | Q92993 | |
| DKSRKPSRWDTSKHE | 676 | Q9BRR8 | |
| PSRWDTSKHEKKEDS | 681 | Q9BRR8 | |
| KKPDKHEDNRRSWAS | 331 | Q8WWI1 | |
| WAKLSAKKTPAERDS | 651 | Q96M69 | |
| ASSEWPELRLSKRKH | 1226 | Q9UKK3 | |
| SKKHPFLTRKWDADE | 181 | Q8IVV7 | |
| RRKKDSVESHPTWVD | 306 | Q5T9C2 | |
| WKEHKPSSIDRRASD | 686 | Q8WUY3 | |
| TWKREHSKHSSSLPR | 2546 | P25054 | |
| PRFLKHESSREDSKW | 336 | Q86X95 | |
| KESSHRWKESKQPDA | 1701 | A4UGR9 | |
| PASPWDSKKHRSRDR | 546 | Q9H7N4 | |
| HSDWKRRSKSKESMP | 71 | Q96K75 | |
| TETHPAKDETFWKRK | 421 | A2RU30 | |
| EAHLPDDSKDTWKKR | 236 | P40818 | |
| RQESRASDWHSKTKD | 361 | Q96RL1 |